…the cognitive clinic. Apathy is a major problem for people with neurological disorders, and for their carers. In Parkinson’s disease, reduced motivation can be seen separately from depression (and is…
Content Section:
Conference Reports
…the organisations. Presentations from two studies of disease modifying drugs targeting the beta-amyloid pathway in Alzheimer’s disease shifted the meeting to another level, bringing the largest audience of the conference….
Content Section:
Conference Reports
…PBMs might not always be the most appropriate choice of indicator, they have been validated and used in a wide range of clinical areas. For Parkinson’s disease, the EQ-5D has…
Content Section:
Articles
…2017;18(4):323–325. https://doi.org/10.1177/1751143717702929 PMid:29123563 PMCid:PMC5661788 Major RH. Classic descriptions of disease. Springfield, Thomas, 3rd edn 6th printing, 1965 p.548-53. Adams R. Cases of diseases of the heart. Dublin Hosp Reports 1827;4:396-453….
Content Section:
Articles
…the kinship of medical practice with the verbal and visual narratives encountered respectively in literature and art is obvious. In focusing on brain disease as portrayed in novels, theatre, and…
Content Section:
Book Reviews
…reading level of approximately three grades higher than the recommended “eighth-grade” level suggested by The American Medical Association, National Institutes of Health, and Centers for Disease Control and Prevention (CDC)…
Content Section:
Articles
…requires an MDT approach to capture all facets of this complex disease. Best treatment approach requires that therapy is tailored to each individual’s needs from each MDT member. …
Content Section:
Articles
The 15th Annual Symposium on Neurovascular Disease
Content Section:
Events
…the reporting of MRI by neuroradiologists in routine clinical practice. People with MS receiving disease-modifying treatments (DMT) undergo annual MRI of the central nervous system to monitor disease activity. This…
Content Section:
News Posts